| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |